{
    "organizations": [],
    "uuid": "540859a368dc75b520a5e891d912cd362e4c0424",
    "author": "",
    "url": "https://www.reuters.com/article/brief-valeant-announces-licensing-agreem/brief-valeant-announces-licensing-agreement-with-kaken-pharma-for-psoriasis-treatment-idUSFWN1QH1JN",
    "ord_in_thread": 0,
    "title": "BRIEF-Valeant Announces Licensing Agreement With Kaken Pharma For Psoriasis Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Valeant:\n* ANNOUNCES LICENSING AGREEMENT WITH KAKEN PHARMACEUTICAL CO., LTD. TO DEVELOP AND COMMERCIALIZE NEW CHEMICAL ENTITY FOR PSORIASIS\n* ‍UNDER TERMS OF LICENSING AGREEMENT, KAKEN GRANTED TO CO EXCLUSIVE LICENSE TO DEVELOP AND COMMERCIALIZE TOPICAL PRODUCTS CONTAINING KP-470​\n* ‍WILL HAVE RIGHTS TO DEVELOP AND COMMERCIALIZE PRODUCTS WITH KP-470 IN UNITED STATES, CANADA, AND WESTERN AND EASTERN EUROPE​\n* ‍KAKEN TO RECEIVE UPFRONT CASH PAYMENT AND HAS POTENTIAL TO RECEIVE CERTAIN DEVELOPMENT-BASED MILESTONE PAYMENTS\n* ‍ADDITIONALLY, KAKEN WILL RECEIVE ROYALTIES ON VALEANT‘S NET SALES OF PRODUCTS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T03:02:00.000+02:00",
    "crawled": "2018-02-28T03:24:13.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "valeant",
        "announces",
        "licensing",
        "agreement",
        "kaken",
        "pharmaceutical",
        "develop",
        "commercialize",
        "new",
        "chemical",
        "entity",
        "psoriasis",
        "term",
        "licensing",
        "agreement",
        "kaken",
        "granted",
        "co",
        "exclusive",
        "license",
        "develop",
        "commercialize",
        "topical",
        "product",
        "containing",
        "right",
        "develop",
        "commercialize",
        "product",
        "united",
        "state",
        "canada",
        "western",
        "eastern",
        "receive",
        "upfront",
        "cash",
        "payment",
        "potential",
        "receive",
        "certain",
        "milestone",
        "payment",
        "kaken",
        "receive",
        "royalty",
        "valeant",
        "net",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}